Disclosures for "Effectiveness and Tolerability of Brivaracetam by Number of Lifetime Antiseizure Medications in Adults with Focal Onset Seizures: Pooled Data From Two Real-world Studies")
-
Dr. Martin has received personal compensation for serving as an employee of UCB. Dr. Martin has received stock or an ownership interest from UCB.
-
Dr. Bourikas has nothing to disclose.
-
Mrs. Brock has received personal compensation for serving as an employee of UCB.
-
Dr. Dongre has received personal compensation for serving as an employee of UCB Inc. Dr. Dongre has stock in UCB Inc.
-
Sami Elmoufti has nothing to disclose.
-
Iryna Leunikava has nothing to disclose.
-
Dr. Little has received personal compensation for serving as an employee of UCB.
-
Anne-Liv Schulz has received personal compensation for serving as an employee of UCB. Anne-Liv Schulz has received stock or an ownership interest from UCB.